{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05664074",
            "orgStudyIdInfo": {
                "id": "2022-0640"
            },
            "organization": {
                "fullName": "Children's Hospital Medical Center, Cincinnati",
                "class": "OTHER"
            },
            "briefTitle": "Rectal Indomethacin vs Intravenous Ketorolac",
            "officialTitle": "Post ERCP Pancreatitis Prophylaxis, Effectiveness of Rectal Indomethacin vs Intravenous Ketorolac in the Pediatric Population",
            "therapeuticArea": [
                "Other"
            ],
            "study": "rectal-indomethacin-vs-intravenous-ketorolac"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-02",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-11-07",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-06-01",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-06-01",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-11-23",
            "studyFirstSubmitQcDate": "2022-12-21",
            "studyFirstPostDateStruct": {
                "date": "2022-12-23",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-02-21",
            "lastUpdatePostDateStruct": {
                "date": "2024-02-23",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "David Vitale MD",
                "investigatorTitle": "Assistant Professor",
                "investigatorAffiliation": "Children's Hospital Medical Center, Cincinnati"
            },
            "leadSponsor": {
                "name": "David Vitale MD",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "Endoscopic retrograde cholangiopancreatography (ERCP) is an essential procedure that can be complicated by post-ERCP pancreatitis (PEP). Indomethacin and ketorolac are two medications used to prevent PEP. The main reason for this research study is to compare the effectiveness these drugs at reducing rates of PEP. There have been no studies comparing the effectiveness of these medications in preventing PEP in pediatric patients. You are being asked to take part in this research study because you are scheduled to have an ERCP as part of your medical care."
        },
        "conditionsModule": {
            "conditions": [
                "Post-ERCP Acute Pancreatitis"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "This will be a prospective study where patients will be randomized into either rectal indomethacin or IV ketorolac.",
                "primaryPurpose": "PREVENTION",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "whoMasked": [
                        "PARTICIPANT"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 192,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Rectal indomethacin",
                    "type": "EXPERIMENTAL",
                    "description": "Dosage based on subject's weight:\n\n\\>=50 kg, 100 mg; 30-49 kg, 50 mg; 10-29 kg, 25 mg",
                    "interventionNames": [
                        "Drug: Rectal indomethacin"
                    ]
                },
                {
                    "label": "IV ketorolac",
                    "type": "EXPERIMENTAL",
                    "description": "Dosage based on subject's weight: 0.5 mg/kg (maximum: 15 mg)",
                    "interventionNames": [
                        "Drug: IV ketorolac"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Rectal indomethacin",
                    "description": "Dosage based on subject's weight:\n\n\\>=50 kg, 100 mg; 30-49 kg, 50 mg; 10-29 kg, 25 mg",
                    "armGroupLabels": [
                        "Rectal indomethacin"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "IV ketorolac",
                    "description": "Dosage based on subject's weight: 0.5 mg/kg (maximum: 15 mg)",
                    "armGroupLabels": [
                        "IV ketorolac"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Post-ERCP Pancreatitis",
                    "description": "Number of patient who develop Post-ERCP Pancreatitis-\n\nPost ERCP Pancreatitis: A patient must have at least 2 of the following to establish a diagnosis of post ERCP pancreatitis:\n\n1. Characteristic physical exam findings- pain worse than admission per pain scales (please see point 2) and/or nausea\n2. Amylase (unit/L) or lipase(unit/L) greater than 3 times the age appropriate upper limit of normal.\n\n   * Normal range of amylase (15-127 unit/L)\n   * Normal range of lipase (12-50 unit/L)\n3. Confirmatory imaging (Ultrasound, CT or MRI) that suggests or demonstrates pancreatic inflammation",
                    "timeFrame": "2 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Pain assessed by FLACC or NRS scoring post ERCP",
                    "description": "A minimum of 3 pain assessments are to be completed by nursing staff/anesthesia during admission:\n\nAnesthesia/ PACU- initial pain assessment Evening-2100- pain assessment by RN Morning -0800- pain assessment by RN\n\nFace, Legs, Activity, Cry, and Consolability (FLACC) Pain scale for patients 0-5 years of age and patients unable to verbalize pain\n\nNumeric Rating Scale (NRS) Pain scale for patients 6 years old and above\n\n1. Mild- 0 to 3\n2. Moderate- 4 to 6\n3. Severe- 7 to 10",
                    "timeFrame": "2 weeks"
                },
                {
                    "measure": "Laboratory markers associated PEP (Amylase and Lipase)",
                    "description": "Amylase (unit/L) Lipase (unit/L)",
                    "timeFrame": "2 weeks"
                },
                {
                    "measure": "Length of stay",
                    "timeFrame": "2 weeks"
                },
                {
                    "measure": "Severity of pancreatitis (mild, moderately severe, severe)",
                    "description": "Severity of Acute Pancreatitis (AP): Severity of AP will be classified as mild, moderately severe, or severe in accordance with the NASPGHAN Classification system.\n\n1. Mild: \"AP that is not associated with any organ failure, local or systemic complications, and usually resolves within the first week after presentation.\"\n2. Moderately Severe: \"AP with either the development of transient organ failure/dysfunction (lasting no \\>48 hours) or development of local or systemic complications. Local complications would include development of (peri) or pancreatic complications including fluid collections or necrosis. Systemic complications would include exacerbation of previously diagnosed co-morbid disease (such as lung disease or kidney disease).\"\n3. Severe: \"AP with development of organ dysfunction per International pediatric sepsis consensus conference that persists \\>48 hours. Persistent organ failure may be single or multiple, and may develop beyond the first 48 hours of presentation.\"",
                    "timeFrame": "2 weeks"
                },
                {
                    "measure": "C-Reactive Protein (CRP) level",
                    "description": "Measured in mg/dL",
                    "timeFrame": "2 weeks"
                },
                {
                    "measure": "Post-ERCP bleeding",
                    "timeFrame": "2 weeks"
                },
                {
                    "measure": "White Blood Cell",
                    "description": "per/mcL",
                    "timeFrame": "2 weeks"
                },
                {
                    "measure": "Red Blood Cell",
                    "description": "per/mcL",
                    "timeFrame": "2 weeks"
                },
                {
                    "measure": "Hemoglobin",
                    "description": "gm/dL",
                    "timeFrame": "2 weeks"
                },
                {
                    "measure": "Hematocrit",
                    "timeFrame": "2 weeks"
                },
                {
                    "measure": "MCV",
                    "description": "fL",
                    "timeFrame": "2 weeks"
                },
                {
                    "measure": "MCH",
                    "description": "pg",
                    "timeFrame": "2 weeks"
                },
                {
                    "measure": "MCHC",
                    "description": "gm/dL",
                    "timeFrame": "2 weeks"
                },
                {
                    "measure": "RDW",
                    "timeFrame": "2 weeks"
                },
                {
                    "measure": "PLATELET",
                    "description": "per/mcL",
                    "timeFrame": "2 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Any patient undergoing ERCP (diagnostic or therapeutic with cannulation of the major or minor papilla)\n* Age 6 month- 21 years old\n* Does not meet exclusion criteria\n\nExclusion Criteria:\n\n* \\< 10 kg\n* Low risk subgroup: Biliary indication with history of prior biliary sphincterotomy.\n* High risk for bleeding (Example: Planned liver biopsy)\n* Gastrointestinal bleeding in previous 3 days\n* Acute pancreatitis (within 3 days) at the time of ERCP\n* Use of NSAIDs in the previous 5 days\n* Peptic ulcer disease\n* Acute kidney Injury or Known Chronic Kidney Disease per KDIGO\n* Pregnancy (Pregnancy tests are administered prior to ERCP as standard of care)\n* Lithium therapy\n* Allergy to ketorolac or indomethacin\n* Organ Dysfunction or SIRS",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "6 Months",
            "maximumAge": "21 Years",
            "stdAges": [
                "CHILD",
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Tyler Thompson, BS",
                    "role": "CONTACT",
                    "phone": "513-517-1055",
                    "email": "tyler.thompson@cchmc.org"
                },
                {
                    "name": "Ethan Estes",
                    "role": "CONTACT",
                    "phone": "513-803-4322",
                    "email": "James.Estes@cchmc.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "David Vitale, MD",
                    "affiliation": "Children's Hospital Medical Center, Cincinnati",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Cincinnati Children's Hospital Medical Center",
                    "status": "RECRUITING",
                    "city": "Cincinnati",
                    "state": "Ohio",
                    "zip": "45229",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 39.12713,
                        "lon": -84.51435
                    }
                }
            ]
        }
    },
    "documentSection": {
        "largeDocumentModule": {
            "largeDocs": [
                {
                    "typeAbbrev": "SAP",
                    "hasProtocol": false,
                    "hasSap": true,
                    "hasIcf": false,
                    "label": "Statistical Analysis Plan",
                    "date": "2022-10-24",
                    "uploadDate": "2022-12-08T14:46",
                    "filename": "SAP_000.pdf",
                    "size": 500191
                },
                {
                    "typeAbbrev": "ICF",
                    "hasProtocol": false,
                    "hasSap": false,
                    "hasIcf": true,
                    "label": "Informed Consent Form",
                    "date": "2022-11-02",
                    "uploadDate": "2022-12-08T14:47",
                    "filename": "ICF_001.pdf",
                    "size": 999049
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000010195",
                    "term": "Pancreatitis"
                }
            ],
            "ancestors": [
                {
                    "id": "D000010182",
                    "term": "Pancreatic Diseases"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M13115",
                    "name": "Pancreatitis",
                    "asFound": "Pancreatitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13102",
                    "name": "Pancreatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T170",
                    "name": "Acute Graft Versus Host Disease",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000020910",
                    "term": "Ketorolac"
                },
                {
                    "id": "D000007213",
                    "term": "Indomethacin"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000894",
                    "term": "Anti-Inflammatory Agents, Non-Steroidal"
                },
                {
                    "id": "D000018712",
                    "term": "Analgesics, Non-Narcotic"
                },
                {
                    "id": "D000000700",
                    "term": "Analgesics"
                },
                {
                    "id": "D000018689",
                    "term": "Sensory System Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000000893",
                    "term": "Anti-Inflammatory Agents"
                },
                {
                    "id": "D000018501",
                    "term": "Antirheumatic Agents"
                },
                {
                    "id": "D000016861",
                    "term": "Cyclooxygenase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000006074",
                    "term": "Gout Suppressants"
                },
                {
                    "id": "D000015149",
                    "term": "Tocolytic Agents"
                },
                {
                    "id": "D000012102",
                    "term": "Reproductive Control Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M22645",
                    "name": "Ketorolac",
                    "asFound": "Esophageal",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10257",
                    "name": "Indomethacin",
                    "asFound": "Tyrosine",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4218",
                    "name": "Anti-Inflammatory Agents, Non-Steroidal",
                    "relevance": "LOW"
                },
                {
                    "id": "M4217",
                    "name": "Anti-Inflammatory Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4032",
                    "name": "Analgesics",
                    "relevance": "LOW"
                },
                {
                    "id": "M20786",
                    "name": "Analgesics, Non-Narcotic",
                    "relevance": "LOW"
                },
                {
                    "id": "M20604",
                    "name": "Antirheumatic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M19209",
                    "name": "Cyclooxygenase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M17869",
                    "name": "Tocolytic Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "ARhu",
                    "name": "Antirheumatic Agents"
                },
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Repr",
                    "name": "Reproductive Control Agents"
                }
            ]
        }
    },
    "hasResults": false
}